Prof David Kaye
Professor Kaye is the Director of Cardiology and a senior cardiologist in the Heart Failure & Transplant service at The Alfred.
Professor Kaye is an NHMRC Senior Principal Research Fellow and Head of the Cardiology Division at the Baker Heart and Diabetes Institute.
He is recognised internationally for his work on the pathophysiology of heart failure. His studies have identified a range of the fundamental mechanisms that contribute to the progressive nature of heart failure. He has published over 340 research articles, his H index is 77, with over 23,000 citations.
Research
Professor Kaye holds numerous research grants including an NHMRC Program Grant (as leader), NHMRC Centre of Research Excellence Grant and an NHMRC Development Grant.
Prof Kaye’s research has also created a substantial portfolio of intellectual property related to the invention of novel medical devices. These have been the basis for the formation of three start-up companies, including Osprey Medical which was successfully listed on the ASX. All companies have advanced active clinical trial programs.
Prof Kaye is the recipient of the Eric Susman and RT Hall Prizes for research excellence from the College of Physicians and Cardiac Society. He was awarded the 2012 Eureka Prize for Medical Research Translation.
Most significant clinical trial
A novel formulation of a drug used to treat advanced heart failure, now tested in over 40 patients with severe symptoms.
Publications
View all publications on PubMed
Baker Heart and Diabetes Research Institute Profile